P2Y(12) inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial

BACKGROUND: It remains unclear whether P2Y(12) monotherapy, especially clopidogrel, following short-duration dual antiplatelet therapy (DAPT) is associated with favorable outcomes in patients undergoing complex percutaneous coronary intervention (PCI). Therefore, this study analyzed the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Ji Woong, Hahn, Joo-Yong, Oh, Ju-Hyeon, Chun, Woo Jung, Park, Yong Hwan, Jang, Woo Jin, Im, Eul-Soon, Jeong, Jin-Ok, Cho, Byung Ryul, Oh, Seok Kyu, Yun, Kyeong Ho, Cho, Deok-Kyu, Lee, Jong-Young, Koh, Young-Youp, Bae, Jang-Whan, Choi, Jae Woong, Lee, Wang Soo, Yoon, Hyuck Jun, Lee, Seung Uk, Cho, Jang Hyun, Choi, Woong Gil, Rha, Seung-Woon, Kim, Hee-Yeol, Lee, Joo Myung, Park, Taek Kyu, Yang, Jeong Hoon, Choi, Jin-Ho, Choi, Seung-Hyuck, Lee, Sang Hoon, Gwon, Hyeon-Cheol, Kim, Dong-Bin, Song, Young Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747822/
https://www.ncbi.nlm.nih.gov/pubmed/34523115
http://dx.doi.org/10.5603/CJ.a2021.0101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747822/
https://www.ncbi.nlm.nih.gov/pubmed/34523115
http://dx.doi.org/10.5603/CJ.a2021.0101

Ejemplares similares